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S U M M A R Y
Background: Fluid leakage remains the hallmark of dengue hemorrhagic fever (DHF). The applicability of
currently recommended predictors of DHF for adults with dengue is questionable as these are based on
studies conducted in children.
Methods: One hundred and two adults with dengue were prospectively followed up to investigate
whether home-based or hospital-based early phase ﬂuid resuscitation has an impact on clinical and
hematological parameters used for the diagnosis of early or critical phase ﬂuid leakage.
Results: In the majority of subjects, third space ﬂuid accumulation (TSFA) was detected on the ﬁfth and
sixth days of infection. The quantity and quality of ﬂuids administered played no role in TSFA. A
reduction in systolic blood pressure appeared to be more helpful than a reduction in pulse pressure in
predicting ﬂuid leakage. TSFA occurred with lower percentage rises in packed cell volume (PCV) than
stated in the current recommendations. A rapid reduction in platelets, progressive reduction in white
blood cells, percentage rises in Haemoglobin (Hb), and PCV, and rises in aspartate aminotransferase and
alanine aminotransferase were observed in patients with TSFA and therefore with the development of
severe illness.
Conclusions: Clinicians should be aware of the limitations of currently recommended predictors of DHF
in adult patients who are receiving ﬂuid resuscitation.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
In the past two decades, there has been a dramatic increase in
the global incidence of dengue and dengue hemorrhagic fever
(DHF)/dengue shock syndrome (DSS).1 More than 2.5 billion
people are now at risk in more than 100 countries worldwide, and
every year approximately 50 million infections occur, including
500 000 cases of DHF and DSS.1 Although dengue was previously
considered an illness mainly affecting children, it is now apparent
that the illness increasingly involves adult populations living in
endemic regions.1–3 Furthermore, recent research highlights
differences in clinical manifestations and disease progression in
adults compared to children, suggesting that separate manage-
ment protocols may be required for adults.3–6 In Sri Lanka dengue
has become the infectious disease of most concern, causing high
morbidity and mortality in both pediatric and adult populations
and, therefore, has direct and indirect economic costs.7,8
Plasma leakage is the most important phenomenon associated
with severe dengue infection.9,10 Profound thrombocytopenia and* Corresponding author. Tel.: +94 11 2953409.
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infection.1,11 In addition, the occurrence of organ-speciﬁc com-
plications, such as hepatitis and hepatic failure, myocarditis, and
encephalitis or encephalopathy, either alone or in combination,
have been increasingly described among adults with dengue.1 The
differences in severity of dengue with age4 and the occurrence of
DSS during the febrile phase of infection,12 compared to its
occurrence during the early afebrile phase in children, suggests
possible differences in pathophysiology of severe dengue in adults.
The World Health Organization (WHO) management guidelines
for severe dengue have been revised frequently since 2007, and the
reviewers themselves highlight the need for reﬁnements to disease
classiﬁcations and clearer guidance for detecting severe illness
based on further research.1 As most of the known pathophysiologi-
cal mechanisms of dengue still remain valid, the use of clinical and
hematological parameters to detect plasma leakage remains the
mainstay of detecting severe illness.1 However, the current WHO
guidelines for severity assessment and volume replacement are
based on the studies of DHF and DSS in children.1,3
Patients with suspected dengue are often hospitalized for
monitoring, although only severe cases of dengue and DHF need
institutionalized care.13 The reason for this is that there are no
diagnostic or prognostic tools available to distinguish severeses. Published by Elsevier Ltd. All rights reserved.
Table 1
WHO classiﬁcation of dengue infections and grading of severity of DHFa
DF/DHF Grade Signs and symptoms Laboratory
DF Fever with two of the following:
headache, retro-orbital pain, myalgia, arthralgia/bone pain,
rash, hemorrhagic manifestations
No evidence of plasma leakage
WBC 5  109/l
Thrombocytopenia (platelet count <100  109/l)
Rising hematocrit (5–10%)
No evidence of plasma loss
DHF I Fever and hemorrhagic manifestations (positive tourniquet test)
and evidence of plasma leakage
Thrombocytopenia (<100  109/l)
Hematocrit rise >20%
II As in grade I, plus spontaneous bleeding Thrombocytopenia (<100  109/l)
Hematocrit rise >20%
III As in grade I or II, plus circulatory failure (weak pulse, narrow
pulse pressure (20 mmHg), hypotension, restlessness)
Thrombocytopenia (<100  109/l)
Hematocrit rise >20%
IV As in grade III, plus profound shock with undetectable blood pressure and pulse Thrombocytopenia (<100  109/l)
Hematocrit rise >20%
WHO, World Health Organization; DF, dengue fever; DHF, dengue hemorrhagic fever; WBC, white blood cell count.
a This classiﬁcation was ﬁrst introduced in ‘‘Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. WHO: Geneva; 1997’’, available at http://
www.denguevirusnet.com/guidelines/19-guidelines/42-who-dengue-guidelines-and-documents.html; it is available in the most recent guidelines: page 26 of
‘‘Comprehensive guidelines for prevention and control of dengue and dengue haemorrhagic fever—revised and expanded edition. Geneva: WHO; 2011’’ (Ref. 1). The WHO
classiﬁcation of dengue infections and grading of severity of DHF is available at http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/.
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illnesses at an early stage.13 Most studies that have attempted to
differentiate severe from mild dengue have been conducted in
children.3 In children, plasma leakage and, therefore, the
development of the critical phase, is thought to occur around
the time of defervescence and tends to last for about 48 h.1
However, these studies showed that it was difﬁcult to differentiate
mild from severe dengue until the critical phase developed.13 In
contrast to children, we have experienced many adult patients
developing third space ﬂuid accumulation (TSFA) during early
illness and developing critical illness during the febrile phase of
dengue.12
The current recommended approach for the detection of
dengue fever and the varying degrees of DHF are given in
Table 1.1 According to the classiﬁcation, in addition to clinical
features, the detection of dengue fever includes a white blood cell
(WBC) count of 5  109/l, platelet count of <150  109/l, and a
rising hematocrit of 5–10% without TSFA. The different grades of
DHF are based on critical phase plasma leakage (indicated by a rise
in packed cell volume (PCV) 20%), and as the disease progresses
there is a progressive weakness of pulse, narrow pulse pressure
(20 mmHg), hypotension, and ﬁnally profound shock. However,
the presence of TSFA is considered the most objective evidence for
plasma leakage, while hypoalbuminemia is considered supporting
evidence.1 However, the value of hematological parameters is
limited when baseline values are not available, and are doubtful in
the presence of anemia, hemorrhage, and during the early phase of
ﬂuid resuscitation.1 In order to prevent intravascular ﬂuid
depletion and maintain effective circulatory volume during the
early phase, patients are often advised to consume adequate
amounts of ﬂuids, mainly solutes, at home. Unlike children, most
adults are likely to comply with advice to increase ﬂuid intake. It is
also common practice to administer intravenous ﬂuids to most
hospitalized patients at maintenance rates or less in order to
ensure an effective circulatory volume and venous access. This may
mask the clinical and hematological parameters of early ﬂuid
leakage and at the same time lead to the development of TSFA.
Furthermore, in many resource-poor tropical settings where
dengue is endemic, facilities for imaging to detect TSFA are not
readily available and an exclusively clinical approach can be
subjective.
This study aimed to investigate whether home-based or
hospital-based early phase ﬂuid resuscitation contributes to TSFA
and has an impact on clinical and hematological parameters used
for the diagnosis of early or critical phase ﬂuid leakage (degrees of
DHF) and to investigate the timing and predictors of TSFA.2. Methods
Over a 6-month period from July 2011, adult patients (age
>12 years) who were clinically suspected of having dengue on
admission to the Professorial Medical Unit, Colombo North
Teaching Hospital, Ragama, Sri Lanka, were prospectively
followed up using clinical, hematological, and biochemical
parameters, and observed for the development of TSFA by serial
ultrasonography of the chest and the abdomen. All patients who
were later conﬁrmed to have acute dengue by ELISA (PanBio
Dengue Duo-antibody Test, Australia) and the hemagglutination
inhibition test, were further studied. Data were collected
prospectively on all patients suspected to have dengue using a
detailed interviewer-administered form, and details of those in
whom dengue was conﬁrmed were entered into a Microsoft
Access database and analyzed using the SPSS software package
version 16.
As TSFA is the hallmark of varying degrees of DHF, clinical,
hematological, and biochemical parameters, including those
recommended in the WHO guidelines as being predictive of
severity, were compared between those who developed TSFA and
those who did not, in an attempt to detect critical illness during
preliminary phase ﬂuid resuscitation.
Oral temperature was measured using a mercury thermometer.
A visual analogue scale numbered from 0 to 9 was used for
assessment of symptom severity (generalized weakness and body
pains). Blood pressure measurements were done using a mercury
sphygmomanometer with the patient in the supine position. Oral
ﬂuid intake was measured by asking the patients to use a uniform
measuring cup given on admission. Information on the quantity
and type of intravenous ﬂuids was obtained from the medical
records. In patients who were not catheterized, urine output in
females was measured after collecting urine into a bed pan, and in
male patients urinating directly into a measuring jar.
All biochemical investigations and hematological investiga-
tions were carried out from the same laboratory to maintain the
uniformity of results. Detection of TSFA was done using a semi-
portable Toshiba Ultrasound Machine with a 3 MHz ultrasound
probe.
All patients were managed according to the local guidelines for
the management of adult dengue, published by the Ministry of
Health, Sri Lanka, in collaboration with the Ceylon College of
Physicians in 2010.5
Means were compared using the independent samples t-test,
and equal variance was checked with Levene’s test. Predictability
of the development of TSFA by other parameters was calculated
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correlation was used to assess correlations between parameters.
3. Results
Out of 168 patients who were selected for the study on
admission to hospital, 102 (52 males; mean (standard deviation
(SD)) age 28.3 (11.8) years) were conﬁrmed as having an acute
dengue infection. TSFA was detected in seven of these 102 patients
(6.8%) at the time of admission (the mode (range) duration of
illness in these seven patients at admission was 4 (3–5) days) and
in 34 of 95 (37%) after admission. Of the 34/95 (36%) who
developed TSFA after admission, 33 developed pleural effusion at a
mean duration of 5.4 days (SD 1.4) and 21 developed ascites at
mean duration of 5.8 days (SD 1.4) of illness (1/21 did not have
pleural effusion). The majority of pleural effusions (72.7%) lasted 3
or more days and most cases of ascites (52.4%) lasted less than
3 days.
In the comparison of clinical, hematological, and biochemical
parameters between those who had TSFA and those who did not at
the time of admission to hospital, the parameters that were
signiﬁcantly different were lower platelet count and WBC count,
and a higher aspartate aminotransferase (AST) (Table 2). None of
the other parameters were signiﬁcantly different. When compar-
ing these parameters in patients who developed TSFA afterTable 2
Comparison of parameters between those who developed and those who did not deve
Comparison of parameters at admission
Parameter TSFA 
Total number 7/102 
Illness duration at admission, days, mode/range 4 (3–5) 
Body weakness 7.5 (2.1) 
Body aches 5.4 (2.7) 
Hemoglobin, g/dl 14.7 (2) 
Packed cell volume, l/l 43.8 (6.5)
WBC count, /l 7  109 (3
Platelets, /l 24  109 (
AST, IU/l 291.8 (17
ALT, IU/l 162.6 (89
Systolic BP, mmHg 104.3 (11
Diastolic BP, mmHg 71.4 (13.5
Mean pulse pressure, mmHg 32.8 (7.6)
Comparison of parameters when TSFA developed after admission
Parameter TSFA 
Total number 34/95 
Illness duration at development, days 5.6 (1.4)
Body weakness 7.32 (1.8) 
Body aches 7.29 (1.9) 
Average consumption of water, ml 620 (514) 
Average consumption of solutes, ml 1461 (548) 
Average ﬂuid balance, ml 1041 (472) 
Highest hemoglobin, g/dl 14.66 (1.82) 
Highest packed cell volume, l/l 44.16 (5.19) 
Lowest WBC, /l 3.5  109 (1.5) 
Lowest platelets, /l 30  109 (20) 
Lowest systolic BP, mmHg 99.7 (14.51) 
Lowest diastolic BP, mmHg 65.2 (9.6) 
Lowest mean pulse pressure, mmHg 29.9 (9.1) 
Maximum % rise in Hb, g/dl 8.7 (8.5) 
Maximum % rise in packed cell volume 8.6 (8.7) 
Maximum % reduction in WBC count 15.4 (20.5) 
Maximum % reduction in platelets 50.6 (34.3) 
Maximum % reduction in systolic BP 7.5 (8.6) 
Maximum % reduction in diastolic BP 8 (9.5) 
Maximum % drop in pulse pressure 11.4 (18.2) 
Maximum AST, IU/l 424.1 (253.3) 
Maximum ALT, IU/l 210.4 (149.9) 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BP, blood pressure; SD
a Results are mean (SD), unless stated otherwise.admission and those who did not, signiﬁcant differences were
noted in the mean lowest WBC count, the mean lowest platelet
count, the maximum percentage rises in Hb and PCV, the
percentage reduction in mean systolic blood pressure, and the
average maximum positive ﬂuid balance (Table 2). None of the
others were signiﬁcantly different.
Parameters that signiﬁcantly predicted TSFA are given in
Table 3. The onset of TSFA could be predicted using: a 6.5% rise in
PCV (sensitivity 61%, speciﬁcity 62%), a rise of 6.1% in Hb
(sensitivity 55%, speciﬁcity 64%), lowest recorded platelet count
of 48.5  109/l or less (sensitivity of 83%, speciﬁcity 51%), post-
admission positive ﬂuid balance of more than 777 ml/day
(sensitivity 65%, speciﬁcity 64%), and a 6.5% reduction in systolic
blood pressure (sensitivity of 50%, speciﬁcity of 66%). Non-
signiﬁcant parameters are given in Table 4. The duration of TSFA
was negatively correlated with WBC count (r = 0.361, p = 0.020)
and platelet count (r = 0.585, p = 0.000). There was no signiﬁcant
correlation with admission weight (p = 0.125), duration of fever
(p = 0.387), lowest pulse pressure (p = 0.299), alanine aminotrans-
ferase (ALT) (p = 0.241), AST (p = 0.328), average ﬂuid intake per
day (p = 0.118), or ﬂuid balance per day (p = 0.129). The duration of
pleural effusion showed a signiﬁcant positive correlation with
severity of body aches (assessed on a visual analogue scale)
(r = 0.523, p = 0.001), maximum percentage rise in PCV (r = 0.526,
p = 0.001), and maximum percentage rise in Hb (r = 0.525,lop third space ﬂuid accumulationa
Non-TSFA p-Value
34/95
4 (2–6)
6.9 (1.4) 0.326
6.6 (2.3) 0.221
13.6 (1.8) 0.1
 41.2 (5) 0.19
.6) 3.8  109 (2.1) 0.055
12) 94  109 (52) 0.000
3.8) 137.3 (137.8) 0.022
.7) 91.3 (85.1) 0.078
.3) 104.8 (13.1) 0.926
) 70.9 (9.1) 0.887
 33.8 (8.4) 0.761
Non-TSFA p-Value
61/95
7.16 (1.4) 0.63
7.31 (1.7) 0.96
491 (322) 0.14
1481 (374) 0.83
691 (425) 0.000
14.28 (1.6) 0.3
43.4 (4.5) 0.46
2.7  109 (1.3) 0.01
49  109 (26) 0.000
97.9 (8.91) 0.46
64.8 (7.7) 0.84
28.4 (4.9) 0.37
4.6 (5.2) 0.02
4.5 (5.5) 0.006
15.1 (19.3) 0.95
47.7 (23.4) 0.63
3.9 (5.8) 0.04
7.5 (8.7) 0.74
9.8 (16.7) 0.69
244.3 (251.0) 0.03
185.9 (210.8) 0.56
, standard deviation; TSFA, third space ﬂuid accumulation; WBC, white blood cell.
Table 4
Parameters not showing a signiﬁcant association with predicting third space ﬂuid
accumulation
Parameter p-Value
% rise of AST 0.881
% rise of ALT 0.810
Post-admission average water intake 0.342
Post-admission average solute intake 0.684
% reduction of pulse pressure 0.985
ALT, alanine aminotransferase; AST, aspartate aminotransferase.
Table 3
Parameters showing signiﬁcant association with predicting third space ﬂuid
accumulation
Parameter % rise or decline p-Value Sensitivity Speciﬁcity
Hb Rise of 6.1% 0.017 55% 64%
Packed cell volume Rise of 6.5% 0.002 61% 62%
Platelet count <48.5  109/l 0.0000 83% 51%
Input output balance/day >777 ml 0.002 65% 64%
Systolic blood pressure 6.5% 0.042 50% 66%
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the highest AST (r = 0.598, p = 0.002) and highest ALT (r = 0.721,
p = 0.000). The mean lowest WBC count of 3  109/l seen in
patients who developed bilateral pleural effusions (n = 21) was
signiﬁcantly less (p = 0.042) than the mean lowest WBC count of
4.1  109/l in patients with unilateral effusions (n = 12). There was
no signiﬁcant difference in other parameters between these two
groups.
In this cohort, 41/102 patients developed TSFA and platelet
counts <100  109/l, suggesting DHF grade I according to current
WHO criteria.1 However, their maximum percentage increase in
Hb and PCV were 8% and 8.6%, respectively. Only three of 102
patients had a 20% rise in PCV together with systolic blood
pressure <90 mmHg, weak peripheral pulse and TSFA suggestive
of DHF grade III according to current WHO criteria.
4. Discussion
In this study, the occurrence of TSFA during home-based
management for dengue infection was seen in only a small
proportion of patients, and in these patients it occurred during the
febrile phase of the illness on or before the fourth day. Among
patients who developed the complication after admission, TSFA
occurred on the ﬁfth and sixth day of the illness in the majority.
However, ultrasonographic evidence of TSFA was detected as early
as on the third day of illness in some patients, similar to previous
reports in children.14 Pleural effusions occurred earlier and
persisted for longer than ascites, and were the common
ultrasonographic sign of plasma leakage, similar to what has been
observed in children.14 As there was no signiﬁcant difference in the
quantity or quality of ﬂuid intake between those who developed
TSFA and those who did not, the complication seems to be
primarily a result of increased capillary permeability during the
disease process.
Lower platelet counts in the presence of relatively higher WBC
counts and high AST levels were found in patients who developed
TSFA (at admission or after admission) compared to patients who
did not develop TSFA. Furthermore, lower WBC counts were
observed in those who developed bilateral pleural effusions
compared to unilateral effusions. Low platelet and WBC counts
are helpful to differentiate dengue fever from other febrile
illnesses,13 and are associated with the development and
progression of pleural effusions.13,15 A rise in AST levels in severe
dengue has also been documented previously.16,17 Therefore, these
observations predicting severe illness are in keeping with the
previous ﬁndings documented for similar illness in children. The
reduction in systolic blood pressure appeared to be more helpful in
identifying adult patients who developed TSFA than the previously
recommended reduction in pulse pressure.3 Rising Hb and PCV
remained useful as predictors of TSFA. A rise in PCV >6.5%, Hb
>6.1%, the lowest platelet count below 48  109/l, and a positive
ﬂuid balance of 777 ml/day at any time of the illness compared to
baseline while on ﬂuid resuscitation, seemed to predict TSFA and,
therefore, increased vascular permeability. This highlights the
importance of recording baseline values in patients with fever indengue endemic areas. Such data may also help solve some
controversies when developing management guidelines. At
present the availability of such data is very limited in developing
countries where dengue is endemic.18 The duration of TSFA
correlated positively with body aches and the percentage rise in
PCV and Hb, and correlated negatively with WBC count and
platelet count. These parameters are known indicators of plasma
leakage in dengue,1 and remain valid as predictors of severe
dengue in adults during ﬂuid resuscitation.
In this cohort, although 41/102 patients had TSFA and platelet
counts <100  109/l without signiﬁcant hemodynamic compromise
mimicking DHF grade I according to current WHO criteria,1 their
maximum percentage increase in Hb and PCV were 8% and 8.6%,
respectively, and were far below the recommended values for the
detection of DHF grade I.1Only three of 102 patients had 20% rise in
PCV, and all of them developed features suggestive of DHF grade III
according to current WHO criteria.1 Clinicians should be aware that
patients who are on ﬂuid resuscitation during the early phases of
infection can develop DHF grade I without the expected rise in PCV,
and rises 20% seem to indicate more severe stages of DHF.
This study highlights some limitations in the use of predictors
of severity that are given in current dengue management
guidelines for detecting and categorizing stages of severe dengue
in adults in the phase of preliminary phase ﬂuid resuscitation. This
may be because these guidelines are based on pediatric studies.
However, a rapid reduction in platelet counts, progressive
reduction in WBC counts, percentage rises in Hb and PCV,
reductions in systolic blood pressure, and rises in AST and ALT
seem useful in detecting ﬂuid leakage and therefore the develop-
ment of severe illness.
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